← Open Payments lookup

KEVIN PRICE: Open Payments

NPI 1043241334 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$444 in 16 payments from 9 companies in 2025. Trend: 2023 $95 · 2024 $75 · 2025 $444

Food & beverage: $444
CompanyPaymentsAmount
Axsome Therapeutics, Inc.2$145
Neurocrine BioSciences, Inc.3$66
Otsuka America Pharmaceutical, Inc.3$58
Lundbeck LLC2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
E.R. Squibb & Sons, L.L.C.1$32
Vanda Pharmaceuticals Inc.1$30
ABBVIE INC.1$18
Teva Pharmaceuticals USA, Inc.1$15

Products named: Auvelity, REXULTI, INGREZZA, CAPLYTA, COBENFY, FANAPT, VRAYLAR, AUSTEDO XR.

Industry payments across AR — which companies pay providers there.